Stay updated on Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial
Sign up to get notified when there's something new on the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page.

Latest updates to the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page shows a revision update from v3.3.3 to v3.3.4, a minor site version change that does not affect study details or user workflow. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA consolidated Locations section has been added with updated site listings across multiple regions (e.g., California, Ontario, New South Wales). The revision label shows v3.3.3, and the older per-location subsections have been removed.SummaryDifference1%

- Check51 days agoChange DetectedThe page shows a revision label change from v3.2.0 to v3.3.2, with no changes to study content or details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check58 days agoChange DetectedThe government funding operating status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check73 days agoChange DetectedPage content and structure appear unchanged; there were no additions or deletions between the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check101 days agoChange DetectedUpdated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.SummaryDifference4%

Stay in the know with updates to Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page.